Why do pharmaceutical companies fight against intermittent fasting? | Dr. Reda Bakhs in the podcast "An"

Podcast briefing

Dr. Reda discusses the implications of intermittent fasting and the pharmaceutical industry’s stance on it.

In this episode, Dr. Reda shares insights on intermittent fasting, emphasizing its potential health benefits while critiquing the pharmaceutical industry's resistance to it. He argues that traditional dietary habits could be contributing to increased metabolic disorders.